Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Peptic Ulcer Testing - A World Market Intelligence Report' returned 4 results - Page 1 of 1   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Future Infectious Disease Testing Market: Growth Opportunities and Business Expansion Strategies   Venture Planning Group, Nov 2011, Pages: 1900 Dyspepsia b. Diagnostic Tests c. Vaccines and Drugs - Specific Therapeutic Regimens - Who Should Be Treated? - Participants in Controlled Clinical Trials - Patients with Refractory Peptic Ulcer - Patients Global Microbiology Testing Market: US, Europe, Japan - Emerging Opportunities and Business Expansion Strategies for Suppliers   Venture Planning Group, June 2011, Pages: 1900 ELISA c. Vaccines and Drugs 32. Helicobacter Pylori a. Background 0 Pathogenesis 0 Role in Peptic Ulcer Disease 0 Role in Gastric Cancer 0 Nonulcer Dyspepsia b. Diagnostic Tests c. Vaccines and Drugs 0 2012 Global Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies   Venture Planning Group, April 2012, Pages: 1900 - Pathogenesis - Role in Peptic Ulcer Disease - Role in Gastric Cancer - Nonulcer Dyspepsia b. Diagnostic Tests c. Vaccines and Drugs - Specific Therapeutic Regimens - Who Should Be Treated? - Participants Takeda Pharmaceutical Company Limited: Company Profile and SWOT Analysis   iCD Research, Sep 2011, Pages: 44 guarantee a unique report. Scope - Examines and identifies key information and issues about Takeda Pharmaceutical Company Limited for business intelligence requirements - Studies and presents the company Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets2    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network